Addex Therapeutics Announces Executive Management Changes
Addex Therapeutics (SIX and NASDAQ:ADXN) announced executive management changes. The company is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.